Free Trial

UnitedHealth Group (NYSE:UNH) Rating Lowered to Hold at Hsbc Global Res

UnitedHealth Group logo with Medical background

UnitedHealth Group (NYSE:UNH - Get Free Report) was downgraded by research analysts at Hsbc Global Res from a "strong-buy" rating to a "hold" rating in a research note issued on Tuesday,Zacks.com reports.

Several other equities analysts have also recently issued reports on the company. Piper Sandler decreased their price objective on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research note on Thursday, January 2nd. Wells Fargo & Company dropped their price target on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 28th. Morgan Stanley dropped their price target on UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating on the stock in a research report on Tuesday. HSBC restated a "hold" rating and issued a $490.00 target price on shares of UnitedHealth Group in a research note on Tuesday. Finally, Argus downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have given a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of "Buy" and a consensus price target of $603.05.

Get Our Latest Report on UNH

UnitedHealth Group Trading Down 1.4 %

UNH stock traded down $6.05 during trading on Tuesday, reaching $418.20. 9,255,934 shares of the stock were exchanged, compared to its average volume of 4,474,545. The firm has a market capitalization of $382.53 billion, a price-to-earnings ratio of 26.98, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The business has a 50 day moving average price of $504.95 and a 200-day moving average price of $536.14. UnitedHealth Group has a 1 year low of $412.10 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the previous year, the firm earned $6.91 EPS. On average, research analysts predict that UnitedHealth Group will post 29.54 earnings per share for the current year.

Institutional Trading of UnitedHealth Group

Institutional investors and hedge funds have recently modified their holdings of the company. NewSquare Capital LLC acquired a new stake in UnitedHealth Group during the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at $26,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth about $28,000. Aster Capital Management DIFC Ltd bought a new stake in UnitedHealth Group during the fourth quarter worth about $30,000. Finally, AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $30,000. 87.86% of the stock is currently owned by institutional investors.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines